Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > Medmira multiplo syphilis test
View:
Post by Scotty19 on May 30, 2022 10:34pm

Medmira multiplo syphilis test

The testing was just featured on CBC news THE NATIONAL tonight along with a competitors test kit. The trial has been on going for 19 months and will continue in Saskatchewan later this year Dr. Ameeta Singh who headed up the trials said this is going to be an incredible game changer. Both products need full Health Canada approval before they can be used widespread.
Comment by Scotty19 on May 31, 2022 6:55am
The competitor is bioLytical in Richmond BC. Their test kits are branded as Insti tests. The company is privately owned.
Comment by Summerhill68 on May 31, 2022 2:22pm
Why would this be game changer when MIR has had it out in the market for years with a 98/99% + rating.  More bullshit just on another stokhouse board
Comment by Scotty19 on May 31, 2022 3:08pm
Just not Health Canada approved so if it is then there should be sales. Maybe you should watch the clip because the doctor who made the comment is independent of both companies
Comment by satchmo6 on Jun 02, 2022 10:20am
an old afliction-- mostly in under developed countries---- trying for a breakout somewhere
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities